Antimicrobial stewardship in patients with confirmed coronavirus disease 2019 (COVID-19)

Infect Control Hosp Epidemiol. 2022 Nov;43(11):1698-1700. doi: 10.1017/ice.2021.351. Epub 2021 Aug 2.

Abstract

Hospitalized coronavirus disease 2019 (COVID-19) patients receiving antibiotics (n = 173) were retrospectively assigned to the early or late discontinuation groups. The length of therapy was shorter in the early discontinuation group (3 vs 7 days; P < .0001). Mortality rates (14.3% vs 20.7%; P = .316) and length of stay (7 vs 9 days; P = .063) were similar.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antimicrobial Stewardship*
  • COVID-19 Drug Treatment*
  • Hospitalization
  • Humans
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents